Trump Sets 2028 Tariffs Up To 200% On Imported Generic Drugs
President Trump announced 100% tariffs on imported generic drugs starting August 2028, rising to 200% after one year, in a move unveiled on Tuesday, July 21, 2026, in Washington.[1]
The White House said the plan includes a two-year transition and will be backed by incentives such as full expensing of equipment and earlier reshoring commitments tied to other drug-tariff programs.[1] Regulators say generic drugs make up about 90% of U.S. prescriptions, with India supplying more than half and China providing most imported ibuprofen and acetaminophen.[1] Economists Marta Wosińska and Mariana Socal told CBS they doubt tariffs alone will rebuild large-scale U.S. generic manufacturing and expect at least some higher costs to reach consumers.[1]
The White House has used similar tariff threats and incentives under previous drug-tariff programs to win reshoring commitments from manufacturers.[1]
Show source details & analysis (1 source)
📌 Key Facts
- On Tuesday, July 21, 2026, President Trump announced 100% tariffs on imported generic drugs starting August 2028, rising to 200% after one year.
- The FDA says generics account for about 90% of prescriptions filled in the U.S., with India supplying more than 50% and China providing most imported ibuprofen and acetaminophen.
- Experts Marta Wosińska and Mariana Socal told CBS they doubt tariffs alone will bring large-scale generic manufacturing back to the U.S. and expect at least some higher costs to reach consumers.
- The White House says the plan gives a two-year transition period and will be supported by measures like full equipment expensing and prior reshoring commitments under other drug-tariff programs.
📰 Source Timeline (1)
Follow how coverage of this story developed over time